Preinfection laboratory parameters may predict COVID‐19 severity in tumor patients

Abstract Background Infection with SARS‐CoV‐2 leads to COVID‐19, the course of which is highly variable and depends on numerous patient‐specific risk factors. Patients with tumor diseases are considered to be more susceptible to severe COVID‐19; however, they also represent a heterogeneous group of...

Descripció completa

Dades bibliogràfiques

Autors principals:	Alexander Kiani, Romina Roesch, Clemens M. Wendtner, Frank Kullmann, Thomas Kubin, Thomas Südhoff, Marinela Augustin, Markus Schaich, Clemens Müller‐Naendrup, Gerald Illerhaus, Frank Hartmann, Holger Hebart, Ruth Seggewiss‐Bernhardt, Martin Bentz, Ernst Späth‐Schwalbe, Peter Reimer, Ulrich Kaiser, Markus Kapp, Ullrich Graeven, Jens‐Marcus Chemnitz, Jörg Baesecke, Helmut Lambertz, Ralph Naumann
Format:	Artigo
Idioma:	Inglês
Publicat:	Wiley 2021-07-01
Col·lecció:	Cancer Medicine
Matèries:	biomarkers cancer COVID‐19 neutrophils SARS‐CoV‐2 tumor
Accés en línia:	https://doi.org/10.1002/cam4.4023
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!